|Articles|April 1, 2014
- BioPharm International-04-01-2014
- Volume 27
- Issue 4
BioPharm International, April 2014 Issue (PDF)
Click the title above to open the BioPharm International April 2014 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 11 years ago
Line of Environmental Measurement Productsover 11 years ago
UPLC Separation Intergrates into Mass Spectrometersover 11 years ago
FDA and Manufacturers Seek a More Secure Drug Supply Chainover 11 years ago
High-Performance Separation-Electrospray Ionization Systemover 11 years ago
Biotech IPOs on a Hot Streakover 11 years ago
Global Instability Affects the Pharma Market in Brazilover 11 years ago
Raw Material Variabilityover 11 years ago
Monoclonal Antibodies Key to Unlocking the Biosimilars Marketover 11 years ago
Publishing Beyond the Printed PageNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Biologics, Obesity, China Top Financial Trends Reshaping Pharma R&D in J.P. Morgan Report
2
Biotech Equipment Market to Approach $144B by 2030: Implications for Pharma R&D
3
Everything to Know About Cell and Gene Therapy in 2025
4
Why Product-Specific Strategies Matter in Advanced Therapy Manufacturing (Part 3)
5
